These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19899977)

  • 1. Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction.
    Shii D; Nakagawa S; Shinomiya K; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Curr Eye Res; 2009 Jun; 34(6):426-37. PubMed ID: 19899977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
    Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
    Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of cyclosporine a eye drops on symptoms in late phase and delayed-type reactions in allergic conjunctivitis models.
    Shii D; Nakagawa S; Yoshimi M; Katsuta O; Oda T; Nakamura M
    Biol Pharm Bull; 2010; 33(8):1314-8. PubMed ID: 20686224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models.
    Sengoku T; Sakuma S; Satoh S; Kishi S; Ogawa T; Ohkubo Y; Mutoh S
    Clin Exp Allergy; 2003 Nov; 33(11):1555-60. PubMed ID: 14616868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Administration of β-1,3-Glucan to Modulate Allergic Conjunctivitis in a Murine Model.
    Lee HS; Kwon JY; Joo CK
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1352-60. PubMed ID: 27002295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of thymoquinone on ovalbumin-induced allergic conjunctivitis in Balb/c mice.
    Hayat K; Asim MB; Nawaz M; Li M; Zhang L; Sun N
    Curr Eye Res; 2011 Jul; 36(7):591-8. PubMed ID: 21604966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of a T-helper type 2 clone into conjunctiva induces corneal damage in mice.
    Shii D; Oda T; Nakamura M
    Cornea; 2010 Feb; 29(2):197-203. PubMed ID: 20023576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
    Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
    Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
    Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
    Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide dismutase 3 attenuates experimental Th2-driven allergic conjunctivitis.
    Lee HJ; Kim BM; Shin S; Kim TY; Chung SH
    Clin Immunol; 2017 Mar; 176():49-54. PubMed ID: 28063939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration in goblet cell numbers and mucin gene expression in a mouse model of allergic conjunctivitis.
    Kunert KS; Keane-Myers AM; Spurr-Michaud S; Tisdale AS; Gipson IK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2483-9. PubMed ID: 11581187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
    Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
    Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TSLP and downstream molecules in experimental mouse allergic conjunctivitis.
    Zheng X; Ma P; de Paiva CS; Cunningham MA; Hwang CS; Pflugfelder SC; Li DQ
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3076-82. PubMed ID: 20107175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
    Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
    Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease.
    Calder VL; Jolly G; Hingorani M; Adamson P; Leonardi A; Secchi AG; Buckley RJ; Lightman S
    Clin Exp Allergy; 1999 Sep; 29(9):1214-22. PubMed ID: 10469030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoring conjunctival tolerance by topical nuclear factor-κB inhibitors reduces preservative-facilitated allergic conjunctivitis in mice.
    Guzmán M; Sabbione F; Gabelloni ML; Vanzulli S; Trevani AS; Giordano MN; Galletti JG
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(9):6116-26. PubMed ID: 25190648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
    Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
    Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
    Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.